The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

Without a growing base of revenue, it's hard to craft a compelling ... PEP), and Moderna (NASDAQ: MRNA). Candy company Hershey is trading near its 52-week low. Moderna (MRNA) stock surged 7% ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...

Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...

With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor ...

Testing new antibiotics in India, South Africa, or Brazil, where they are needed most, makes scientific sense. But it’s not ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other S&P 500 stocks ... us or make multinational companies move their manufacturing base here to a ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...